Julia Maltzman, M.D., has served as Adicet Bio's Chief Medical Officer since January 2025. She previously served as Chief Medical Officer of IconOVir Bio from September 2022 to January 2025, leading a clinical development program focused on refractory solid tumors.
Before that she held leadership roles at Roche/Genentech, as VP and Global Head of GI Cancers and Cancer Immunotherapy and earlier as Group Medical Director, Cancer Immunotherapy. She received her M.D. from the University of Colorado, completed her internship and residency in Internal Medicine at the University of Chicago, and completed a fellowship in Hematology/Oncology at the University of Pennsylvania. She holds a B.A. in Political Science from the University of Colorado.